ED
APLS icon

Exane Derivatives’s Apellis Pharmaceuticals APLS Stock Holding History

Exane Derivatives’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,589
Closed -$68.2K – 1028
2021
Q1 		$68.2K Buy
+1,589
New +$68.2K 0.02% 470